Acute stroke therapies

Bednar, 1996, Combination tissue plasminogen activator and ticlopidine therapy in a rabbit model of acute thromboembolic stroke, Neurol Res, 18, 45, 10.1080/01616412.1996.11740376 Bell, 1984, Defibrinogenation with Arvin in thrombotic disorders, 272 Bowes, 1995, Monoclonal antibodies preventing leukocytes activation reduced experimental neurological injury and enhance efficacy of thrombolytic therapy, Neurology, 45, 815, 10.1212/WNL.45.4.815 Chang, 1995, The antiplatelet activity of ancrod on administration to rabbits, J Lab Clin Med, 125, 508 del Zoppo, 1988, Local intra-arterial fibrinolytic therapy in acute carotid territory stroke; a pilot study, Stroke, 19, 307, 10.1161/01.STR.19.3.307 Friedman, 1996, Tissue plasminogen activator for acute ischemic stroke, N Engl J Med, 334, 1405, 10.1056/NEJM199605233342114 Hacke, 1994, Thrombolytic therapy in acute ischemic stroke: an update, Fibrinolysis, 8, 216, 10.1016/0268-9499(94)90719-6 Hacke, 1995, Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke, JAMA, 274, 1017, 10.1001/jama.1995.03530130023023 Hacke, 1988, Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease, Stroke, 19, 1216, 10.1161/01.STR.19.10.1216 Helgason, 1994, Development of aspirin resistance in persons with previous ischemic stroke, Stroke, 25, 2331, 10.1161/01.STR.25.12.2331 Hossman, 1983, Controlled trial of ancrod in ischemic stroke, Arch Neurol, 40, 803, 10.1001/archneur.1983.04050120053007 Hull, 1992, Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis, New Engl J Med, 326, 975, 10.1056/NEJM199204093261502 Kay, 1995, Low molecular weight heparin for the treatment of acute ischemic stroke, N Engl J Med, 333, 1588, 10.1056/NEJM199512143332402 Lutomski, 1995, Pharmacokinetic optomization of the treatment of embolic disorders, Clinical Pharmacokinetics, 28, 67, 10.2165/00003088-199528010-00006 Mori, 1992, Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke, Neurology, 42, 976, 10.1212/WNL.42.5.976 Multicentre Acute Stroke Trial-Italy, 1995, Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke, Lancet, 346, 1509, 10.1016/S0140-6736(95)92049-8 1995, Tissue plasminogen activator for acute ischemic stroke, N Engl J Med, 333, 1581, 10.1056/NEJM199512143332401 Sherman, 1994, Ancrod for the treatment of acute ischemic brain infarction, Stroke, 25, 1755, 10.1161/01.STR.25.9.1755 1992, A randomised comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41,299 cases of suspected acute myocardial infarction, Lancet, 339, 753, 10.1016/0140-6736(92)91893-D von Kummer, 1992, Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke, Stroke, 23, 646, 10.1161/01.STR.23.5.646 Zeumer, 1983, Intra-arterial thrombolysis in vertebrobasilar thromboembolic disease, Am J Neuroradiol, 4, 401